Anzeige
Mehr »
Login
Freitag, 19.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Goldaktie: Eine Erfolgsgeschichte, die seinesgleichen sucht, startet gerade richtig durch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
158 Leser
Artikel bewerten:
(0)

S&P Indices Announces Changes to U.S. Index

NEW YORK, April 18, 2012 /PRNewswire/ -- S&P Indices will make the following changes to the S&P SmallCap 600 index:

  • OpenTable, Inc. (NASD: OPEN) will replace ZOLL Medical Corp. (NASD: ZOLL) after the close of trading on Friday, April 20. Asahi Kasei Corp. is acquiring ZOLL in a deal expected to be completed soon, pending final conditions.
  • Spectrum Pharmaceuticals, Inc. (NASD: SPPI) will replace Midas, Inc. (NYSE: MDS) after the close of trading on Tuesday, April 24. Midas is being acquired by TBC Corp. in a deal expected to be completed soon pending final conditions.

OpenTable is a provider of real-time online restaurant reservations for diners and reservation and guest management solutions for restaurants. Headquartered in San Francisco, CA, the company will be added to the S&P SmallCap 600 GICS (Global Industry Classification Standard) Internet Software & Services Sub-Industry index.

Spectrum Pharmaceuticals acquires, develops, and commercializes prescription drug products. Headquartered in Henderson, NV, the company will be added to the S&P SmallCap 600 GICS Biotechnology Sub-Industry index.

Following is a summary of the changes:

S&P SMALLCAP 600 INDEX - April 20, 2012


COMPANY

GICS ECONOMIC SECTOR

GICS SUB-INDUSTRY

ADDED

OpenTable

Information Technology

Internet Software & Services

DELETED

ZOLL Medical

Health Care

Health Care Equipment

S&P SMALLCAP 600 INDEX - April 24, 2012


COMPANY

GICS ECONOMIC SECTOR

GICS SUB-INDUSTRY

ADDED

Spectrum Pharmaceuticals

Health Care

Biotechnology

DELETED

Midas

Consumer Discretionary

Automotive Retail

About S&P Indices

S&P Indices, a leading brand of the McGraw-Hill Companies (NYSE: MHP), maintains a wide variety of investable and benchmark indices to meet an array of investor needs. Over $1.45 trillion is directly indexed to our indices, which includes the S&P 500, the world's most followed stock market index, the S&P/Case-Shiller Home Price Indices, the leading measure of U.S. home prices, the S&P Global BMI, an index with approximately 11,000 constituents, the S&P GSCI, the industry's most closely watched commodities index, and the S&P National AMT-Free Municipal Bond Index, the premier investable index for U.S. municipal bonds. For more information, please visit: www.standardandpoors.com/indices.

It is not possible to invest directly in an index. S&P Indices does not sponsor, endorse, sell, or promote any S&P index-based investment product. This document does not constitute an offer of services in jurisdictions where S&P Indices or its affiliates do not have the necessary licenses. S&P Indices receives compensation in connection with licensing its indices to third parties.

For more information:

Dave Guarino
Communications
S&P Indices
dave_guarino@standardandpoors.com
212-438-1471

David Blitzer
Managing Director and Chairman of the Index Committee
S&P Indices
david_blitzer@standardandpoors.com
212-438-3908

SOURCE S&P Indices

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2012 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.